Literature DB >> 1116873

Hepatitis B antigen in saliva, urine, and stool.

G R Irwin, A M Allen, W H Bancroft, J J Karwacki, H L Brown, R H Pinkerton, M Willhight, F H Top.   

Abstract

A survey of hepatitis B patients, asymptomatic hepatitis B antigen (HBsAg) carriers, and control subjects was conducted to determine the relationship between antigenemia and antigen excretion in saliva, urine, and stool. Radioimmunoassay was used to detect HBsAg. Specificity-confirmed HBsAg was detected in the saliva of 6 (30%) of 20 antigenemic patients, 1 (5%) of 20 nonantigenemic patients, 14 (34%) of 41 carriers, and 0 of 112 controls. HBsAg was detected in urine only after 100-fold concentration of first-morning specimens. Specificity-confirmed HBsAg was present in the urine of 7 (16%) of 43 carriers; unconfirmed HBsAg was found in the urine of 5 (13%) of 38 patients and 5 (5%) of 112 controls. Unconfirmed HBsAg was detected in concentrated stool specimens from 5 (46%) of 11 patients and 3 of 8 carriers and controls. Longitudinally collected specimens from antigenemic subjects showed no consistent patterns of antigen excretion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116873      PMCID: PMC415037          DOI: 10.1128/iai.11.1.142-145.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

2.  Menstrual blood as a vehicle of Australia-antigen transmission.

Authors:  S Mazzur
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

3.  Hepatitis-B antigen in saliva and semen.

Authors:  J Heathcote; C H Cameron; D S Dane
Journal:  Lancet       Date:  1974-01-19       Impact factor: 79.321

4.  Hepatitis B antigen in saliva and mouth washings.

Authors:  R Ward; P Borchert; A Wright; E Kline
Journal:  Lancet       Date:  1972-10-07       Impact factor: 79.321

5.  Australia antigen in urine.

Authors:  K Apostolov; D J Bauer; J W Selway; R A Fox; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

6.  Limitations of the radioimmunoassay for hepatitis B antigen (HB Ag).

Authors:  J T Sgouris
Journal:  N Engl J Med       Date:  1973-01-18       Impact factor: 91.245

7.  Familial clustering of hepatitis B infection.

Authors:  W Szmuness; A M Prince; R L Hirsch; B Brotman
Journal:  N Engl J Med       Date:  1973-11-29       Impact factor: 91.245

8.  The Ausria test: critical evaluation of sensitivity and specificity.

Authors:  H J Alter; P V Holland; R H Purcell; J L Gerin
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

9.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  Hepatitis B antigen inhibitor in human faeces and intestinal mucosa.

Authors:  M Piazza; G Di Stasio; G Maio; L A Marzano
Journal:  Br Med J       Date:  1973-05-12
View more
  7 in total

1.  Feasibility of routine testing for hepatitis B surface antigen in hospital employees and restriction of carriers.

Authors:  W D Leers; G M Kouroupis; A Dong
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

2.  Potential risk of salivary-mediated viral hepatitis type B transmission from oral exposure to fomites.

Authors:  M T Osterholm; B J Max; M Hanson; H F Polesky
Journal:  J Hyg (Lond)       Date:  1979-12

Review 3.  Risk and management of blood-borne infections in health care workers.

Authors:  E M Beltrami; I T Williams; C N Shapiro; M E Chamberland
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 4.  [Clinical aspects of non-tumorous diseases of the salivary glands].

Authors:  J Haubrich
Journal:  Arch Otorhinolaryngol       Date:  1976

5.  Deficient knowledge on hepatitis B infection in pregnant women and prevalence of hepatitis B surface antigen carriage in an endemic area: a review.

Authors:  Oi Ka Chan; Terence T Lao; Stephen S H Suen; Tak Yeung Leung
Journal:  Hepat Res Treat       Date:  2012-09-28

6.  Passive immunization against exposure to hepatitis B virus in the military: potential and possibilities.

Authors:  G R Irwin
Journal:  Yale J Biol Med       Date:  1976-07

7.  Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice.

Authors:  Haruki Komatsu; Ayano Inui; Takeyoshi Murano; Tomoyuki Tsunoda; Tsuyoshi Sogo; Tomoo Fujisawa
Journal:  BMC Res Notes       Date:  2015-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.